Cc1nn(C2CCOC(C)(C)C2)c2c1C(c1ccc(OC(C)C)cc1)SCC(=O)N2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?